COMBINATION MEDICINE OF TEMOZOLOMIDE AND MUTANT IDH1 ENZYME INHIBITOR

To provide combination medicines with excellent effects on cancers with IDH1 gene mutations that can reduce the dose of temozolomide without reducing the antitumor effect.SOLUTION: The present invention is completed by finding that the combination of temozolomide and a mutant IDH1 enzyme inhibitor c...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: SEKI TAKEHIKO
Format: Patent
Sprache:eng ; jpn
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator SEKI TAKEHIKO
description To provide combination medicines with excellent effects on cancers with IDH1 gene mutations that can reduce the dose of temozolomide without reducing the antitumor effect.SOLUTION: The present invention is completed by finding that the combination of temozolomide and a mutant IDH1 enzyme inhibitor can reduce the dose of temozolomide without reducing the antitumor effect.SELECTED DRAWING: None 【課題】 本発明の課題は、抗腫瘍作用を低下させずにテモゾロミドの投与量を削減することができる、IDH1遺伝子変異を有するがんに対して優れた効果を有する組み合わせ医薬を提供することである。【解決手段】 テモゾロミドと変異型IDH1酵素阻害剤を組み合わせることで、抗腫瘍作用を低下させずにテモゾロミドの投与量を削減することができることを見出し、本発明を完成するに至った。【選択図】 なし
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2022021331A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2022021331A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2022021331A3</originalsourceid><addsrcrecordid>eNqNyrEKwjAQgOEsDqK-w-EumOYJ0uRKTrw7kXOwSykSJ9FCfX908AGEH77lXzpMyi1JNFIBxkyJBEE7MGTt9ahMGSFKBr5YFAPKxQNKf2UEkkItmZ7XbnEfH3Pd_Fy5bYeWyq5Or6HO03irz_oeDqdm33zzIfgY_po-0lYsUA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMBINATION MEDICINE OF TEMOZOLOMIDE AND MUTANT IDH1 ENZYME INHIBITOR</title><source>esp@cenet</source><creator>SEKI TAKEHIKO</creator><creatorcontrib>SEKI TAKEHIKO</creatorcontrib><description>To provide combination medicines with excellent effects on cancers with IDH1 gene mutations that can reduce the dose of temozolomide without reducing the antitumor effect.SOLUTION: The present invention is completed by finding that the combination of temozolomide and a mutant IDH1 enzyme inhibitor can reduce the dose of temozolomide without reducing the antitumor effect.SELECTED DRAWING: None 【課題】 本発明の課題は、抗腫瘍作用を低下させずにテモゾロミドの投与量を削減することができる、IDH1遺伝子変異を有するがんに対して優れた効果を有する組み合わせ医薬を提供することである。【解決手段】 テモゾロミドと変異型IDH1酵素阻害剤を組み合わせることで、抗腫瘍作用を低下させずにテモゾロミドの投与量を削減することができることを見出し、本発明を完成するに至った。【選択図】 なし</description><language>eng ; jpn</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220202&amp;DB=EPODOC&amp;CC=JP&amp;NR=2022021331A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220202&amp;DB=EPODOC&amp;CC=JP&amp;NR=2022021331A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SEKI TAKEHIKO</creatorcontrib><title>COMBINATION MEDICINE OF TEMOZOLOMIDE AND MUTANT IDH1 ENZYME INHIBITOR</title><description>To provide combination medicines with excellent effects on cancers with IDH1 gene mutations that can reduce the dose of temozolomide without reducing the antitumor effect.SOLUTION: The present invention is completed by finding that the combination of temozolomide and a mutant IDH1 enzyme inhibitor can reduce the dose of temozolomide without reducing the antitumor effect.SELECTED DRAWING: None 【課題】 本発明の課題は、抗腫瘍作用を低下させずにテモゾロミドの投与量を削減することができる、IDH1遺伝子変異を有するがんに対して優れた効果を有する組み合わせ医薬を提供することである。【解決手段】 テモゾロミドと変異型IDH1酵素阻害剤を組み合わせることで、抗腫瘍作用を低下させずにテモゾロミドの投与量を削減することができることを見出し、本発明を完成するに至った。【選択図】 なし</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQgOEsDqK-w-EumOYJ0uRKTrw7kXOwSykSJ9FCfX908AGEH77lXzpMyi1JNFIBxkyJBEE7MGTt9ahMGSFKBr5YFAPKxQNKf2UEkkItmZ7XbnEfH3Pd_Fy5bYeWyq5Or6HO03irz_oeDqdm33zzIfgY_po-0lYsUA</recordid><startdate>20220202</startdate><enddate>20220202</enddate><creator>SEKI TAKEHIKO</creator><scope>EVB</scope></search><sort><creationdate>20220202</creationdate><title>COMBINATION MEDICINE OF TEMOZOLOMIDE AND MUTANT IDH1 ENZYME INHIBITOR</title><author>SEKI TAKEHIKO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2022021331A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; jpn</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SEKI TAKEHIKO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SEKI TAKEHIKO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMBINATION MEDICINE OF TEMOZOLOMIDE AND MUTANT IDH1 ENZYME INHIBITOR</title><date>2022-02-02</date><risdate>2022</risdate><abstract>To provide combination medicines with excellent effects on cancers with IDH1 gene mutations that can reduce the dose of temozolomide without reducing the antitumor effect.SOLUTION: The present invention is completed by finding that the combination of temozolomide and a mutant IDH1 enzyme inhibitor can reduce the dose of temozolomide without reducing the antitumor effect.SELECTED DRAWING: None 【課題】 本発明の課題は、抗腫瘍作用を低下させずにテモゾロミドの投与量を削減することができる、IDH1遺伝子変異を有するがんに対して優れた効果を有する組み合わせ医薬を提供することである。【解決手段】 テモゾロミドと変異型IDH1酵素阻害剤を組み合わせることで、抗腫瘍作用を低下させずにテモゾロミドの投与量を削減することができることを見出し、本発明を完成するに至った。【選択図】 なし</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; jpn
recordid cdi_epo_espacenet_JP2022021331A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title COMBINATION MEDICINE OF TEMOZOLOMIDE AND MUTANT IDH1 ENZYME INHIBITOR
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T05%3A31%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SEKI%20TAKEHIKO&rft.date=2022-02-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2022021331A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true